Form 4: Integra LifeSciences Executive Eric Schwartz Reports Changes in Beneficial Ownership

Eric Schwartz, EVP, Chief Legal Officer & Secretary of Integra LifeSciences, reports transactions involving company stock, including acquisitions and disposals to cover tax obligations.

Summary

• On March 11, 2024, Eric Schwartz disposed of 1,371 shares of common stock at $36.22 to cover tax obligations.
• On the same day, he acquired 7,745 shares of common stock and another 8,283 shares of common stock.
• On March 12, 2024, he disposed of 1,090 shares and 348 shares of common stock at $35.88 to cover tax obligations.
• Following these transactions, Schwartz directly owns 63,581 shares of Integra LifeSciences common stock.
• Schwartz also acquired 17,890 non-qualified stock options with an exercise price of $36.22, vesting in four equal installments annually from March 11, 2024.
• Following these transactions, Schwartz directly owns 17,890 derivative securities.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing primarily reports transactions related to stock options and tax obligations, which are common occurrences. The acquisitions are slightly positive, but the disposals offset this.

Positives

• The acquisition of 7,745 and 8,283 shares by a company executive could be seen as a positive signal.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Comparison to Industry Standards

• Executive stock transactions are common across publicly traded companies.
• The vesting schedule of the stock options (25% annually) is a standard practice.
• Similar filings can be compared to those of executives at companies like Stryker (SYK) or Medtronic (MDT) to understand typical executive compensation and stock ownership patterns in the medical device industry.

Stakeholder Impact

• The transactions could have a minor impact on shareholders' perception of management's confidence in the company.
• The disposal of shares to cover tax obligations is a normal part of executive compensation and is unlikely to have a significant impact on other stakeholders.

Key Dates